Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Senti Biosciences, Inc. - Common Stock (NQ: SNTI ) 2.650 -0.060 (-2.21%) Streaming Delayed Price Updated: 3:53 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Senti Biosciences, Inc. - Common Stock < Previous 1 2 Next > Senti Bio to Present Preclinical Data for SENTI-202 at the 2022 ASH Annual Meeting November 03, 2022 Poster presentation to highlight preclinical data for SENTI-202 which employs Logic Gating gene circuit technology in off-the-shelf CAR-NK cells designed to more precisely target CD33 and/or FLT3... From Senti Biosciences, Inc. Via GlobeNewswire Senti Bio Announces New Employment Inducement Grants October 28, 2022 From Senti Biosciences, Inc. Via GlobeNewswire Senti Bio to Present Preclinical Data on Cancer-Killing Allogeneic CAR-NK Cells at SITC Annual Meeting October 05, 2022 Abstracts highlight Senti Bio’s continued progress in applying gene circuits to improve the cytotoxicity and persistence of allogeneic CAR-NK cells for the potential treatment of solid tumors From Senti Biosciences, Inc. Via GlobeNewswire R&D Efforts to Improve Optimal Treatments for Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Progressing October 05, 2022 Palm Beach, FL – October 5, 2022 – FinancialNewsMedia.com News Commentary – Advanced pancreatic ductal adenocarcinoma (PDAC) remains a significant cause of mortality accounting for up to 4% of all... Via FinancialNewsMedia Topics Death Exposures Death < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.